Saturday , 22 February 2025
0

No products in the cart.

Worldwide News Worldwide News
0

No products in the cart.

Home Health SEC Charges Ipsen Worker for Insider Trading Tied to $247M Epizyme Acquisition
Health

SEC Charges Ipsen Worker for Insider Trading Tied to $247M Epizyme Acquisition

September 11, 20241 Mins read54 Views
SEC Charges Ipsen Worker for Insider Trading Tied to $247M Epizyme Acquisition

Securities regulators say the role of Ipsen employee Dishant Gupta made him privy to details of the Epizyme acquisition. Gupta allegedly accumulated Epizyme shares while the deal was negotiated, then sold all of them hours after the transaction was announced.

The post SEC Charges Ipsen Worker for Insider Trading Tied to $247M Epizyme Acquisition appeared first on MedCity News.

Previous post Housing market in UK shows signs of recovery - RICS house price best since January 2020

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

A paper by Proudman et al. (2024) finds that doing so would...

ByFebruary 22, 2025
Health

Carlyle and SK Capital Partners are buying beleaguered gene therapy biotech Bluebird...

ByFebruary 21, 2025

This fact sheet provides an overview of the history of the Kemp-Kasten...

ByFebruary 21, 2025

Katherine Saunders is the co-founder and CMO at FlyteHealth. She was one...

ByFebruary 21, 2025

Abous us

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis

Subscribe Now

    Subscribe to our mailing list to receives daily updates direct to your inbox!
    © Copyright 2022 Jellywp. All rights reserved powered by Jellywp.com